EUVIMEDEUVIMED entdecken
Crossref

Addressing surgical challenges in patients with severe form of osteogenesis imperfecta and with prolonged bisphosphonate treatment: intramedullary sclerosis and technical solutions

Željko Jeleč, Dragan Primorac, Vilim Molnar, Darko Antičević

International Orthopaedics · 2025

DOI: 10.1007/s00264-025-06645-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Orthopaedics, 2025. Verfasst von Željko Jeleč und 3 weiteren Autor:innen. Beteiligte Einrichtung: St. Catherine Specialty Hospital, Zagreb, Croatia. zeljko.jelec@svkatarina.hr. Hauptthemen laut MEDLINE: Osteogenesis Imperfecta, Diphosphonates, Bone Density Conservation Agents. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Osteogenesis imperfecta (OI) is commonly managed with bisphosphonates (BPs) which are associated with significant side effects. This study aimed to investigate intramedullary sclerosis as a potential side effect of prolonged BP use in paediatric patients. METHODS: Thirteen children with OI underwent surgery at our hospital. We assessed 21 non-operated bone segments from 13 paediatric patients using a tailored protocol to measure sclerosis severity and its impact on surgical outcomes. RESULTS: Among 21 non-operated segments, 17 exhibited intramedullary sclerosis. Pamidronate cycles inversely correlated with the percentage of the sclerosing area and varus deformity, plateauing after 15 cycles. Angulation in the sagittal plane decreased progressively. CONCLUSIONS: Our study introduces intramedullary sclerosis as a possible novel BP-related side-effect in pediatric OI patients. Our findings suggest a critical review of prolonged BP therapy in OI patients, advocating for a surgical intervention threshold after fifteen BP cycles to mitigate complications and optimize treatment outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Osteogenesis ImperfectaDiphosphonatesBone Density Conservation AgentsHumansFemaleMaleChildAdolescentSclerosisChild, PreschoolTreatment OutcomePamidronateSeverity of Illness IndexRetrospective Studies

Stichwörter der Autor:innen

Intramedullary sclerosisOsteogenesis imperfectaProlonged bisphosphonate treatmentSide effects

Substanzen

DiphosphonatesBone Density Conservation AgentsPamidronate

Autor:innen und Institutionen

  • St. Catherine Specialty Hospital, Zagreb, Croatia. zeljko.jelec@svkatarina.hr.
  • University North, Department of Physiotherapy, Varaždin, Croatia. zeljko.jelec@svkatarina.hr.
  • St. Catherine Specialty Hospital, Zagreb, Croatia.
  • University of Split, Medical School, Split, Croatia.
  • Josip Juraj Strossmayer University in Osijek, Faculty of Dental Medicine and Health, Osijek, Croatia.

Zitieren

APA

Jeleč, Ž., Primorac, D., Molnar, V., & Antičević, D. (2025). Addressing surgical challenges in patients with severe form of osteogenesis imperfecta and with prolonged bisphosphonate treatment: intramedullary sclerosis and technical solutions. International Orthopaedics. https://doi.org/10.1007/s00264-025-06645-7

Vancouver

Jeleč Ž, Primorac D, Molnar V, Antičević D. Addressing surgical challenges in patients with severe form of osteogenesis imperfecta and with prolonged bisphosphonate treatment: intramedullary sclerosis and technical solutions. International Orthopaedics. 2025. doi:10.1007/s00264-025-06645-7

BibTeX
@article{Jele2025,
  author = {Jeleč, Željko and Primorac, Dragan and Molnar, Vilim and Antičević, Darko},
  title = {Addressing surgical challenges in patients with severe form of osteogenesis imperfecta and with prolonged bisphosphonate treatment: intramedullary sclerosis and technical solutions},
  journal = {International Orthopaedics},
  year = {2025},
  doi = {10.1007/s00264-025-06645-7}
}
Kostenlos starten →